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Abstract: 
Background: 
Enterococci, considered as normal commensal flora in oral cavity, intestines and genital 
tract of humans and animals have emerged as major opportunistic pathogens. Biofilm 
formation is an important virulence factor of enterococci species. Bacteria within biofilm 
are more resistant than their free-living (i.e., planktonic) counterpart. Urinary tract 
infection (UTI) is one of the most frequent types of nosocomial and community acquired 
infections in humans, and biofilm contribute significantly to their virulence and antibiotic 
resistance. The role of bacterial biofilms and antimicrobial resistance has great importance 
for public health. Hence this study was conducted to detect the biofilm formation by 
enterococci isolates from clinical settings and to compare the antibiotic resistance pattern 
of biofilm forming and non- biofilm forming species and to determine what role 
enterococcal surface protein (esp) gene plays in enterococcal biofilm formation. 
Methodology: 
A total of 50 isolates of enterococci were collected from patients, enterococcus species 
were identified using conventional microbiological methods. The antibiotic susceptibility 
patterns of the isolates were determined by the disc diffusion-method. The Microtiter plate 
method used to assess the ability of biofilm formation. All enterococcal isolates were 
examined for determination of esp gene, by polymerase chain reaction (PCR). 
Results: 
Of 50 enterococcal isolates, 70 % were recognized as E. faecalis and 30% of them were E. 
faecium. According to our results, overall, 69% of E. faecalis and 40% of E. faecium 
isolates were biofilm producers. Resistance to some antibiotics including ampicillin (36% 
P=0.001), tetracycline (54 % P=0.003), erythromycin (52% P=.004) and vancomycin (24% 
P=.002) was significantly higher among biofilm producers than non-biofilm producers 
enterococci. The esp gene was present in 50% isolates. In this study, there was not a 
significant relationship between presence of esp gene and biofilm formation.    
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Conclusion: 
Biofilm formation is considered an important virulence factor in causing infections by 
enterococci. Our findings reinforce the role of biofilm formation in resistance to 
antimicrobial agents. Biofilm producing isolates were less sensitive to antibiotics than 
biofilm non-formers. biofilm formation decreases their susceptibility to antibiotics. Our 
results suggest that biofilm formation is complex and depends on various factors but not 
just esp gene in Enterococcus strains. Hence screening, timely detection and control of 
biofilm formation is necessary to increase patient outcome. 
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Chapter One: 
____________________________________________________________ 
 
1. Introduction: 
Enterococci are Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic 
bacteria, enterococci are often simply described as lactic-acid–producing bacteria, which 
usually inhabit the alimentary tract of humans in addition to being isolated from 
environmental and animal sources (Rahkila, Johansson et al. 2011). Enterococci are highly 
tolerant to desiccation and can persist for months on dried surfaces. Enterococci also 
tolerate extremes of pH, ionizing radiation, osmotic and oxidative stresses )Ramsey, 
Hartke et al. 2014) 
Enterococci survive or grow over a wide range of temperatures for mesophilic bacteria, 
from 10 to 45°C (Moreno, Sarantinopoulos et al. 2006).  
Enterococci were classified as group D Streptococci (Sherman 1938) until 1984, 
when Streptococcus faecalis and Streptococcus faecium were reclassified as Enterococcus 
faecalis and Enterococcus faecium, respectively  (Schleifer and Kilpper-Bälz 1984). 
Both species, Enterococcus faecalis and Enterococcus faecium cause human diseases, most 
commonly in the form of urinary tract and wound infections. Other infections, including 
those of the blood stream (bacteremia), heart valves (endocarditis), and the brain 
(meningitis) can occur in immunocompromised patients.  
Enterococci also often colonize open wounds and skin ulcers, and are among the most 
common antibiotic-resistant bacteria (Van Tyne and Gilmore 2014). 
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Understanding the ecology, epidemiology and virulence of Enterococcus species is 
important for limiting urinary tract infections, hepatobiliary sepsis, endocarditis (Dahl and 
Bruun 2013), surgical wound infection, bacteremia and neonatal sepsis, to reduce  the 
further development of antibiotic resistance (Moreno, Sarantinopoulos et al. 2006). 
Enterococcaceae considered the second most common cause of nosocomial urinary tract 
infection next to E. coli and third most common cause of bacteremia (Winn and Koneman 
2006). 
The most common enterococci species are Enterococcus faecalis causing about 80 -90% of 
human infection followed by Enterococcus faecium (Stuart, Schwartz et al. 2006). 
 
1.1. Virulence factor: 
 
The virulence factors converged in E. faecalis and E. faecium which have been isolated in 
nosocomial infections, include antibiotic resistance, extracellular proteins (toxins), extra 
chromosome and mobile genetic elements, cell wall components, biofilm formation, 
adherence factors, and colonization factor such as bacteriocin, (Hancock and Gilmore 
2006).  
Other virulence factor such as Extracellular toxins such as cytolysin can induce tissue 
damage, increase mortality in combination with aggregation substance, and cause systemic 
toxicity. And Cell-surface associated factors like Adhesin to collagen of E. faecalis (ace) 
(Vidana 2015), Aggregation substance (asa), Capsular polysaccharide, E. faecalis antigen 
A (efaA), esp gene, serine protease, capsule, and superoxide (Upadhyaya, Ravikumar et al. 
2009). 
 
1.1.1. Biofilm: 
biofilm is a microbially derived sessile community characterized by cells that are 
irreversibly attached to a substratum or interface or to each other, are embedded in a matrix 
of extracellular polymeric substances that they have produced, it contains viable and 
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nonviable microorganism that adhere to the surface (proteins, glycoproteins, and 
carbohydrates) (Arampatzi, Giannoglou et al. 2011). 
Bacteria in biofilm are resistant to phagocytosis, making biofilm extremely difficult to 
eradicate (O'Toole 2011). 
 
According to the National Institutes of Health, biofilm account for over 80 % of microbial 
infections (Lewis 2001), Biofilm associated infections are recurrent, chronic and highly  
resistant to antibiotics, about 10 to 1000 folds of more antibiotic concentrations required to 
kill the bacteria in biofilm than the free living forms (Mohamed and Huang 
2007),(Upadhyaya, Ravikumar et al. 2009). 
 
 
1.1.2. Biofilm formation 
 
The five stages of biofilm development: 
. Stage 1: Planktonic (free floating) bacteria adhere to the biomaterial surface. 
 Stage 2: Cells aggregate, form micro colonies and excrete extracellular polymeric 
substances (EPS), i.e. slime. The attachment becomes irreversible.        
Stage 3: A biofilm is formed. It matures and cells form multi-layered clusters.  
Stage 4: Three-dimensional growth and further maturation of the biofilm, providing 
protection against host defense mechanisms and antibiotics. 
 Stage 5: The biofilm reaches a critical mass and disperses planktonic bacteria ready to 
colonize other surfaces.(Unosson 2015) 
 
 
 
 
 
(Unosson 2015) 
 
Figure 1.1: The five stages of biofilm development.  
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1.1.3. Factors influencing biofilm production: 
 
Nutrient contents of the growth medium, such as glucose, serum, availability of iron, CO 2, 
osmolarity, pH, and temperature influence biofilm production among different bacteria 
(Lim, Jana et al. 2004). Carbohydrate metabolism regulates biofilm production among 
various Gram-positive bacteria, including E. faecalis  (Pillai, Sakoulas et al. 2004). One 
study has shown that tryptic soy broth (TSB) medium with 1 % glucose supplementation 
enhances biofilm production in E. faecalis compared to TSB without glucose (Baldassarri, 
Cecchini et al. 2001). 
 Esp is a cell wall associated protein that has been implicated as a significant factor 
contributing to colonization, persistence of bacteria in the urinary tract and biofilm 
formation. Esp, was initially identified in a virulent gentamicin-resistant  Enterococcus 
faecalis isolate (Strain No.MMH594) (Toledo-Arana, Valle et al. 2001). 
 
1.2. Antibiotic resistant in Enterococci: 
 
Enterococci can survive harsh environmental conditions such as long periods on 
environmental surfaces, including medical equipment, bed rails and doorknobs. They are 
tolerant to heat, chlorine and some alcohol preparations, which may help explain why these 
organisms are widely disseminated in the hospital setting. There are several risk factors for 
developing a nosocomial VRE (vancomycin-resistant Enterococcus) infection: close 
physical proximity to patients infected or colonized with VRE; a long period of 
hospitalization; multiple courses of antimicrobials; hospitalization in long-term facilities, 
surgical units or intensive-care units; solid organ and bone marrow transplantation; co-
morbidities such as diabetes, renal failure or haemodialysis; and the presence of a urinary 
catheter
. 
(Arias and Murray 2012). 
Enterococci are intrinsically resistant to many commonly used antimicrobial agents. All 
enterococci exhibit decreased susceptibility to penicillin and ampicillin, as well as high-
level resistance to most cephalosporins and all semi-synthetic penicillin, as the result of 
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expression of low-affinity penicillin-binding proteins (PBP). For many strains, their level 
of resistance to ampicillin does not preclude the clinical use of this agent. Enterococci are 
also intrinsically resistant to clindamycin, enterococci also have a native resistance to 
clinically achievable concentrations of aminoglycosides, which prevent their use as single 
agents. Although E. faecalis  is naturally resistant to quinupristin-dalfopristin, this 
combination is highly active against E. faecium strains that lack specific resistance 
determinants (Yang, Li et al. 2015). 
Intrinsic resistance, which is encoded within the core genome of all members of the species 
differs from acquired resistance, in that the latter is present in only some members of the 
species and is obtained via the horizontal exchange of mobile genetic elements or via 
selection upon antibiotic exposure (Huycke, Sahm et al. 1998). 
Moderate species-specific intrinsic resistance to aminoglycosides in E. faecium is 
enhanced by a chromosomally encoded rRNA methyltransferase known as EfmM that uses 
S-adenosyl methionine as a methyl donor to methylate a specific residue on 16S rRNA, in 
the context of the 30S ribosomal subunit (Shepard and Gilmore 2002). 
Modifications in Pbp5 are associated with increased resistance to beta-lactams, such as 
ampicillin. For example, the Pbp5-encoding gene found in hospital-associated, ampicillin-
resistant strains of E. faecium differs by ~5% from the corresponding gene in community-
associated, ampicillin-susceptible strains (Garnier, Taourit et al. 2000).  
Most studies that report an association between mutations in Pbp5 and enhanced ampicillin 
resistance have been performed on non-isogenic clinical isolates, in which unknown 
factors other than Pbp5 may influence resistance (Rice, Messer et al. 1995). 
Since its been discovered in 1986, vancomycin-resistant Enterococcus has increasingly 
become a major nosocomial pathogen (O’Driscoll and Crank 2015). 
Screening the  enterococci isolates for antibiotic resistance is a important tool to obtain 
information about the prevalence of VRE and is crucial for controlling the spread of 
bacterial resistance (Olawale, Fadiora et al. 2011) . The Esp gene acts as an adhesion factor 
and is involved in biofilm synthesis. In addition, the fact that it can be transmitted with 
the vanA resistance gene is believed to contribute toward the wide spread of pathogenic 
VRE (Cho, Sung et al. 2011). 
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VRE can survive in the environment for prolonged periods (>1 week), can contaminate 
almost any surface, and can be passed from one patient to another by health care workers 
(Uttley, Collins et al. 1988). Whether VRE colonization leads to infection depends on the 
health status of the patient. Whereas immunocompetent patients colonized with VRE are at 
low risk for infection, immunocompromised host have an increased likelihood of 
developing infection following colonization  (Zirakzadeh and Patel 2006). 
 
 
1.3. Problem statement: 
 
Biofilms pose a serious problem for public health because of the increased resistance of 
biofilm-associated organisms to antimicrobial agents and the potential for these organisms 
to cause infections in patients with indwelling medical devices (Donlan 2002, Upadhyaya, 
Ravikumar et al. 2009). Bacteria in biofilms are resistant to phagocytosis, making biofilms 
extremely difficult to eradicate from living hosts (Lewis 2001). 
 
Detection of biofilm produced by enterococci and correlating them with their antibiotic 
resistant pattern and an understanding of the role of genetic and environmental factors in 
the development of biofilm may lead to improved strategies for biofilm control among 
enterococci (Stewart 2002). 
 
1.4. Aims and Objectives: 
 
 To detect biofilm production by enterococci clinical isolates. 
 
 To determine what role esp gene plays in Enterococcal biofilm formation. 
 
 To determine the antibiotic susceptibility pattern of enterococci to commonly used 
antibiotics.  
 
 To compare biofilm and non-biofilm enterococci producers to their antibiotic 
susceptibility pattern. 
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1.5. Literature Review: 
Enterococcus has been recognized since 1899, when Thiercelin identified it as an intestinal 
organism(Thiercelin 1899); its taxonomy and ecology were reviewed by Klein (Klein 
2003). Many attempts have been made to `distinguish Enterococcus species from 
Streptococcus species. 
In 1937, Sherman classified Streptococcus species into four subgroups: faecal streptococci 
(enterococci), dairy streptococci, viridans group and pyogenous streptococci, Sherman 
noted that the enterococci subgroup included the Lancefield group D streptococci and 
suggested that the latter could be differentiated by hemolytic and proteolytic reactions 
(Sherman 1937). 
In 1994, through the use of DNA hybridization and 16S rRNA sequencing, it was 
established that the species Streptococcus faecalis were distinct from the other streptococci 
to be designated another genus: Enterococcus (Jett, Huycke et al. 1994). 
Traditional methods such as biotyping, serotyping and phage typing left questions as to 
which of the Streptococcus species actually belonged to the genus Enterococcus (Karatan 
and Watnick 2009). 
Fisher and Colleagues classified Enterococcus faecalis as part of the group D 
Streptococcus system is a Gram-positive, commensal bacterium inhabiting the 
gastrointestinal tracts of humans and other mammals. Like other species in the genus 
Enterococcus, E. faecalis can cause life-threatening infections in humans, especially in the 
nosocomial environment, where the naturally high levels of antibiotic resistance found in 
E. faecalis contribute to its pathogenicity (Fisher and Phillips 2009). 
E. faecalis can cause endocarditis and septicemia, urinary tract infections, meningitis, and 
other infections in humans. Several virulence factors are thought to contribute to E. 
faecalis infections. A plasmid-encoded hemolysin, called the cytolysin, is important for 
pathogenesis in animal models of infection, and the cytolysin in combination with high-
level gentamicin resistance is associated with a five-fold increase in risk of death in human 
bacteremia patients. A plasmid-encoded factor called aggregation substance (asa) is also 
important for virulence in animal models of infection (Jett, Huycke et al. 1994). 
Toole and Colleagues defined a biofilm  as communities of microorganisms attached to a 
surface, and occur in response to a variety of environmental signals (O'Toole, Kaplan et al. 
2000). 
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Costerton defined biofilm as a population of cells attached irreversibly on various biotic 
and abiotic surfaces, and encased in a hydrated matrix of exopolymeric substances, 
proteins, polysaccharides and nucleic acids (Costerton 2001). 
The new definition of a biofilm is a microbially derived sessile community characterized 
by cells that are irreversibly attached to a substratum or interface or to each other, are 
embedded in a matrix of extracellular polymeric substances that they have produced and 
exhibit an altered phenotype with respect to growth rate and gene transcription. This 
definition is useful, because some bacterial populations that fulfill the earlier criteria of a 
biofilm, which involves matrix formation and growth at a surface, do not actually assume 
the biofilm phenotype (Arampatzi, Giannoglou et al. 2011). 
Microbes form a biofilm in response to many factors, which may include cellular 
recognition of specific or non-specific attachment sites on a surface, nutritional cues, or in 
some cases, by exposure of planktonic cells to sub-inhibitory concentrations of antibiotics 
(Karatan and Watnick 2009).  
 
In 2001 Baldassarri has shown that tryptic soy broth (TSB) medium with 1 % glucose 
supplementation enhances biofilm formation in E. faecalis compared to TSB without 
glucose (Baldassarri, Cecchini et al. 2001). 
Kristich in 2004 observed that biofilm formation was eliminated by exposure to a medium 
to high osmolarity (2–3 % sodium chloride) without affecting the growth of the bacteria, 
suggesting that E. faecalis monitors the environment and modulates biofilm formation in 
response to specific conditions(Kristich, Li et al. 2004). 
Gallardo noted in his study the effect of human serum on E. faecalis adhesion has been 
examined (Gallardo-Moreno, González-Martín et al. 2002). 
In 2001 Shankar reported Role of esp protein in adherence and colonization. The esp 
protein of E. faecalis is emerged on the cell surface. This localization and enrichment 
among UTI-derived isolates suggested a role for esp in adherence and colonization 
(Shankar, Lockatell et al. 2001). 
Toledo et al (2001) found a relationship between the presence of the esp-encoding gene 
and the biofilm formation by E. faecalis, since 93.5% of the E. faecalis esp-positive 
isolates were capable of forming a biofilm. Moreover, none of the E. faecalis esp-deficient 
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isolates were biofilm producers, and esp promotes primary attachment and biofilm 
production of E. faecalis on abiotic surfaces (Toledo-Arana, Valle et al. 2001). 
Another study was shown that  esp plays a role in esp-mediated biofilm enhancement in 
Enterococcus faecalis (Tendolkar, Baghdayan et al. 2005). 
Another study showed the quantity of biofilm was significantly higher in esp-positive 
compared with esp-negative clinical E. faecium isolates (P < 0.0001). (Tsikrikonis, 
Maniatis et al. 2012) 
In 2010 Upadhyaya concluded in his study that biofilm production has an important role in 
causing nosocomial infection. Although detection of the esp gene correlates with biofilm 
production, it may not be the only factor determining the formation of biofilm since few 
isolates produced biofilm without the esp gene (Upadhyaya, Lingadevaru et al. 2010). 
On the other hand, some studies did not observe any relationship between esp gene and 
biofilm formation, and show that E. faecalis forms complex biofilms and does not require 
the esp surface protein (Kristich, Li et al. 2004), and  no association between the presence 
of esp  and the biofilm formation (Sandoe, Witherden et al. 2003). 
The initial adhesion and production of biofilm are independent of the existence of esp. 
An esp-negative isolate was found to produce biofilm, and two esp-positive isolates did not 
form biofilm  (van Merode, van der Mei et al. 2006). 
 Rosa (2006) have also shown that E. faecalis (36 out of 83) and E. faecium (9 out of 
45) esp-positive isolates were not associated with biofilm formation. However, the same 
authors reported that some esp-positive strains produced thicker biofilms than esp-negative 
biofilm producers (Rosa, Creti et al. 2006). The exact factors, including esp, and 
mechanisms involved in biofilm production by enterococci are still unknown and are an 
area of active investigation. 
 
Although esp did not show strong correlation for biofilm formation, its presence showed a 
significant association with the degree of biofilm production (Mohamed, Huang et al. 
2004). 
Several studies have attempted to identify additional factors that may influence the process 
of biofilm formation in E. faecalis. such as fsr, gelE, epa, atn genes (Mohamed, Huang et 
al. 2004). 
 Polysaccharides have been implicated in biofilm formation. These molecules are 
associated with the cell surface as a capsular polysaccharide or secreted as an exo 
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polysaccharide into the environment. An enterococcal polysaccharide antigen (epa) gene 
cluster mutant of E. faecalis, showed a 73 % reduction in biofilm formation, suggesting 
that this gene encodes a putative glycosyltransferase that is involved in polysaccharide 
synthesis and biofilm production. An E. faecalis autolysin (atn) mutant showed a 30 % 
reduction in biofilm formation. The two-component regulatory system mutant (etaR) 
showed a small reduction in biofilm formation (Mohamed, Huang et al. 2004). 
Another study identified phenotypes linked to the strong biofilm formation of E. faecalis 
E99 by transposon mutagenesis. The gene cluster involved was named biofilm enhancer in 
enterococcus (Tendolkar, Baghdayan et al. 2006). 
Kafil et al (2015) investigated the presence of virulence factors in enterococci strains 
isolated from clinical samples in Iranian Educational hospitals, endocarditis and biofilm-
associated pili (ebp) was present in almost all of E. faecalis, this operon encodes pilus 
components shown to be important for pathogenesis in the endocarditis and UTI (Kafil and 
Mobarez 2015). This operon is also important for biofilm formation. High presence of this 
gene may indicate the importance of biofilm formation for pathogenesis of enterococci in 
clinical isolates,  Results revealed that colonization factors were more prevalent 
in E. faecalis isolates; almost all isolates of E. faecalis contained ace (adhesion of collagen 
from E. faecalis), ebp , efaA genes (Enterococcus faecalis antigen A) and asa (Kafil, 
Mobarez et al. 2013, Kafil and Mobarez 2015)). 
In 2014 a study was carried out by Soares et al reported the correlation between biofilm 
formation and gelE (gelatinase) , esp, and asa genes in Enterococcus spp. clinical isolates, 
more biofilm formation shown by E. faecalis isolates that contain gelE, esp and agg than 
E. faecalis isolates did not contain these virulence genes (Soares, Fedi et al. 2014). 
Hossein et al (2015) found a relationship between virulence profiles and biofilm 
production in clinical UTI isolates. By comparing isolate absorbance, asa1 positive isolates 
had significantly higher biofilm formation than asa1 negative isolates, as well as efaA 
positive isolates had higher biofilm formation than efaA negative isolates, no significant 
differences were found when comparing ace (Adhesion of collagen from E. faecalis) 
positive and -negative isolates. Also esp positive and negative isolates had no significant 
difference in biofilm formation, hyaluronidase (hyl) positive isolates had lower biofilm 
formation tendency, this confirm that the presence of efaA and asa1 correlates with 
increased biofilm formation of urinary tract isolates (Kafil and Mobarez 2015). 
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In 2014 study showed Enterococcus faecium increased resistance to multiple 
antibiotic than Enterococcus faecalis. Significant relationship was found between biofilm 
production with antibiotic resistance to amoxicillin, co-trimoxazole, ciprofloxacin, 
gentamycin, cefotaxime, and cefuroxime, and demonstrated a high propensity among the 
isolates of Enterococci to form biofilm and a significant association of biofilms with 
multiple drug resistance (Akhter, Ahmed et al. 2014). 
Biofilm forming isolates were significantly more resistant to antibiotics like, 
Erythromycin, Penicillin, Norfloxacin, Tetracycline, Ciprofloxacin, 
Amoxycillin/clavulanic acid, Gentamicin, Nitrofurantoin, than biofilm non-forming 
isolates. Resistant pattern of other antibiotics like Amikacin and Vancomycin were 
insignificantly higher for biofilm forming enterococci species. Overall biofilm forming 
enterococcal isolates showed higher resistance patterns than their counterpart. This 
observation is also noted in other studies (Chakraborty, Pal et al. 2015), (Hasan, Al-
Duliami et al.). Other study reported the resistance pattern of biofilm forming Gram 
positive organisms as 100% to Penicillin, 70% to Rifampicin, 40% to Ciprofloxacin, 40% 
to Erythromycin and 30% to Cotrimoxazole and biofilm non-formers were more sensitive 
to these antibiotics, they also observed significant higher resistant of biofilm producing 
enterococci species in their study (Sindhanai, Avanthiga et al. 2016). 
 
Also  another study concluded that the high antibiotic resistance may indicate the intrinsic 
resistance of enterococci is due to circulation of transposable elements carrying resistant 
genes in clinical isolates, indiscriminate and uncontrolled usage of antibiotics and the 
presence of biofilm among the patient isolates (Talebi, Moghadam et al. 2015). 
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Chapter Two: 
____________________________________________________________ 
2. Materials and Methods: 
2.1. Bacterial collection and Identification: 
A total of Fifty non-repetitive clinical isolates of enterococci obtained from   two tertiary 
care centers in West Bank, Palestine (Al-Istishari Hospital and Ramallah Medical 
complex) were tested in this study. The isolates were of wound, rectal, and urine 
specimens (Fig3.1). 
Initial identification of the isolates was done at the two hospitals by gram staining and 
culturing them on bile esculin agar. Further confirmation and speciation of enterococci was 
done at Al-Quds University Laboratory. All the isolates were Gram positive cocci, positive 
bile esculin, positive 6.5% NaCl tests and Catalase negative. 
Enterococcus faecalis was presumptively distinguished from Enterococcus faecium via 
growth and fermentation characteristics on mannitol salt agar, arabinose, sucrose, sorbitol 
and pyruvate fermentation (Sindhanai, Avanthiga et al. 2016). 
The isolates were then stored at -20 
0
C, 50% v/v sterile glycerol/trypticase soy agar. 
 
2.2. Antimicrobial Susceptibility 
Antimicrobial susceptibility testing was performed at Al-Quds University Laboratory on 
Muller Hinton agar (Hi Media, Mumbai) plates by the disc diffusion method according to 
the Clinical and Laboratory Standards Institute (CLSI)  (Square 2012). 
Antibiotics used in our study were Gentamycin, Ciprofloxacin, ampicillin, Erythromycin, 
Tetracycline and Vancomycin (Mast Diagnostics Ltd, UK). 
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2.3. Biofilm Formation Assay by Microtiter plate assay: 
Quantitative determination of biofilm production was performed by using a modified 
Microtiter plate method (Seno, Kariyama et al. 2005) Briefly, Enterococcus isolates were 
grown overnight at 37°C in tryptic soy broth supplemented with 0.5% glucose. The culture 
was diluted1:100 in TSB medium, and 200 μl of this cell suspension was used to inoculate 
sterile flat-bottomed 96-well polystyrene microtiter plates (Corning Inc., Corning, NY, 
USA). The negative control wells contained TSB-0.5% glucose only, after 24 h at 37°C 
without shaking, wells were gently washed three times with 300μl of distilled water, dried 
in an inverted position, and stained with 300 μl crystal violet solution in water for 45 min. 
After staining, plates were washed 3 times with distilled water. Quantitative analysis of 
biofilm production was performed by adding 300 μl of ethanol-acetic acid (95:5, vol/vol) to 
destain the wells. One hundred microtiters from each well was transferred to a new 
microtiter plate and the level (optical density; OD) of crystal violet present in the destaining 
solution was measured at 450 nm using a microtiter plate reader (Seikagaku Co., Tokyo, 
Japan). Optical density of strains was assessed for biofilm formation as follows:  
Weak 0.05-0.1 , Moderate 0.10-0.20, High >0.20 and all were considered positive for 
biofilm production. When the optical density are < 0.05 considered negative (Sindhanai, 
Avanthiga et al. 2016). 
 
2.4. DNA Extraction: 
Boiling method was used for DNA extraction, using a sterile loop, one colony resuspended 
into 50 μl of ultra-pure water then boiling for 10 minutes at 90  C, then it was centrifuged at 
14.000 rpm for 1 minute (Yost and Nattress 2000).  
 
 
 
 
 
 
14 
 
2.4.1. Polymerase chain reaction (PCR) assay: 
PCRs were performed in a final volume of 25 μl containing 12.5 μl from the Taq ready 
Mix (taq ready mix. hy labs) containing Taq DNA Polymerase, dNTPs, Mg2+ and 
Reaction Buffer at optimal concentrations for efficient amplification of DNA templates,1 
μl from each forward and reverse primer, 8.5 μl ultra-pure water and 2 μl from the 
supernatant of the extracted DNA. The reaction mixtures were amplified in a PCR Thermal 
Cycler (ThermoHybaid) with an initial denaturation at 94 
0
C for 10 min, followed by 35 
cycles as follows: Denaturation at 94 
0
C for 1 min, annealing at a temperature 60 
0
C for 1 
min, and extension at 72 
0
C for 1 min, and a final extension step at 72 
0
C for 10 min. 
Negative control was included in each PCR reaction. Positive control strains Enterococcus 
faecalis ATCC 29212 (Marra, Dib-Hajj et al. 2007). 
The amplicons were analysed by electrophoresis in 2 % agarose gels using TAE buffer (pH 
8.0). The gels were stained with ethidium bromide and visualized on a UV trans 
illuminator (Hoefer UV-25; Pharmacia, Biotech). The size of amplified products was 
estimated by comparison with a 100 bp DNA ladder (Amersham; Pharmacia, Biotech) 
(Vankerckhoven, Van Autgaerden et al. 2004), The amplicon size of esp gene with the set 
of primers used was 933 bp. 
The PCR primers used in this study for amplification of esp gene were as follows: 
Esp11: 5′-TTGCTAATGCTAGTCCACGACC-3′(Eaton and Gasson 2001) 
Esp12: 5′-GCGTCAACACTTGCATTGCCGAA-3′ 
 
2.5. Statistical analysis: 
The correlation between the antibiotic resistance, biofilm formation ability and presence of 
the biofilm-related gene among Enterococci isolates was evaluated by the Pearson Chi-
Square test using SPSS version 22. P values less than 0.05 were regarded as significant. 
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Chapter Three: 
______________________________________________________________ 
3. Results: 
3.1. Identification of Enterococcus spp: 
Of the 50 clinical isolates of enterococci, 35 (70%) were E. faecalis and 15 (30%) were E. 
faecium. All the isolated strains were identifiable to the species level. Maximum number of 
the isolates were from urine (56%) followed by rectum (40%) and wound (4%) as shown 
in (fig.3.1). all data about the isolates were shown in Table 3.1. 
Figure 3.1: - Distribution of Enterococci among clinical specimens 
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56% 
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urine
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Table 3.1. Relationship between Enterococcus spp, source, biofilm formation, esp gene 
and VRE 
Isolate 
No. 
species Source of 
isolates 
Biofilm 
formation 
Vancomycin resistant 
enterococcus (VRE) 
ESP gene 
1 E. faecalis Urine Producer VRE Positive 
2 E. faecalis Rectal Non-producer VRE Negative 
3 E. faecalis Urine Producer _ Negative 
4 E. faecalis Urine Non-producer _ Positive 
5 E. faecalis Urine Non-producer VRE Positive 
6 E. faecalis Rectal Non-Producer _ Negative 
7 E. faecalis Urine Producer _ Positive 
8 E. faecalis Rectal Producer VRE Positive 
9 E. faecalis Rectal Producer VRE Positive 
10 E. faecalis Rectal Non-Producer _ Negative 
11 E. faecalis Rectal Producer VRE Positive 
12 E. faecalis Wound Producer _ Negative 
13 E. faecalis   Urine Producer _ Negative 
14 E. faecalis Urine Producer VRE Negative 
15 E. faecalis Urine Producer _ Positive 
16 E. faecalis Urine Producer _ Negative 
17 E. faecalis Wound Producer VRE Positive 
18 E. faecalis Rectal Producer _ Positive 
19 E. faecalis Urine Producer _ Negative 
20 E. faecalis Urine Producer _ Positive 
21 E. faecalis Urine Producer _ Positive 
22 E. faecalis Rectal Producer _ Negative 
23 E. faecalis Rectal Non-producer _ Positive 
24 E. faecalis Urine Producer _ Positive 
25 E. faecalis Urine Producer _ Positive 
26 E. faecalis Rectal Producer VRE Positive 
27 E. faecalis    Rectal Producer _ Positive 
28 E. faecalis Rectal Producer _ Negative 
17 
 
29 E. faecalis Urine Producer _ Negative 
30 E .faecalis Urine Non-producer VRE Negative 
31 E. faecalis Urine Non-producer _ Negative 
32 E. faecalis Rectal Non-producer _ Positive 
33 E. faecalis Urine Producer VRE Negative 
34 E. faecalis Urine Non-producer _ Positive 
35 E. faecalis Rectal Non-producer _ Negative 
36 E. faecium Urine Producer _ Negative 
37 E. faecium Urine Non-producer _ Positive 
38 E. faecium Urine Non-producer VRE Negative 
39 E. faecium Urine Non-producer _ Negative 
40 E. faecium Rectal Producer _ Negative 
41 E. faecium Rectal Producer VRE Positive 
42 E. faecium Urine Non-producer _ Positive 
43 E. faecium Rectal Non-producer _ Negative 
44 E. faecium Rectal Non-Producer _ Negative 
45 E. faecium Urine Non-producer _ Negative 
46 E. faecium Rectal producer VRE Positive 
47 E. faecium Urine Producer _ Positive 
48 E. faecium Urine Non-producer _ Positive 
49 E. faecium Urine Non-producer _ Negative 
50 E. faecium Rectal Producer VRE Negative 
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3.2. Antibiotic susceptibility testing 
The result for antibiotic testing showed that E. faecium in general was more resistant to 
antibiotics than E. faecalis without significant association P > 0.05 (fig3.2). In case of E. 
Faecalis resistance to the following antibiotics tetracycline, erythromycin, and 
ciprofloxacin, were 71%, 66%, 63% respectively, whereas in case of E. faecium tetracycline 
was 73%, erythromycin and ciprofloxacin 80%. For two antibiotic gentamycin and 
vancomycin, E. faecalis was slightly higher in resistance than E. faecium as shown in 
(fig.3.2). 
The result showed about 11 of isolates were resistant to more than  two antibiotic and 
considered multi drug resistant. 
The results showed that vancomycin, ampicillin, and gentamycin were the most effective 
antibiotics against Enterococcus species. 
None of the antibiotics used in the study were 100% effective to all enterococci strains. 
 
 
 
Fig.3.2. Percentage of antibiotic resistant pattern of all Enterococcus spp. to 
different antibiotics 
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3.3. Biofilm production: 
 30 isolates were biofilm producers ( Table 3.2). Of the 35 E. faecalis isolates, 24 (69%) 
were biofilm producers, whereas 15 E. faecium isolates 6 (40%) were biofilm producers 
(Table 3.1). 
Among the E. faecalis isolates 14.3% were strong, 42.8% moderate and 11.4% of them 
were found to be weakly adherent. Whereas among the E. faecium isolates 26.6% moderate 
and 13.3% were found weakly adherent (Table 3.3). 
Antibiotic susceptibility pattern of enterococcal isolates are shown in (Table 3.4).  
 
Statistical analysis indicated that there was a significant association between biofilm 
formation of enterococcal isolates and some antibiotic resistance such as ampicillin 
(36%P=0.001), tetracycline (54 %, P=0.003), erythromycin (50%, p= 0.004), and 
vancomycin (30%, p= 0.002) (Table 3.5). 
 
 
Table 3.2: Prevalence of biofilm forming and non-biofilm forming Enterococci 
Total no. of Enterococci isolates 
[]%  
Biofilm producers Biofilm Non-formers 
50 [100%[ 
 
30]60%[ 20]40%[ 
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Table 3. 3. Biofilm formation ability of Enterococcus species in Microtiter plate 
method 
Method Biofilm 
formation 
E. faecalis 
n=35 
Percent E. faecium 
n=15 
percent Total (%) 
 
 
Microtiter 
plate assay 
Strong 
 
5 14.3% 0 0% 5(10%) 
Moderate 
 
15 42.8% 4 26.6% 19(38%) 
Weak 
 
4 11.4% 2 13.3% 6(12%) 
None 
 
11 31.4% 9 60% 20(40%) 
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Table 3.4: Antibiotic susceptibility pattern of enterococcal isolates 
 
E. faecalis (n=35) 
 
E. faecium (n=15) 
 
 
Antibiotics 
 
 
 
 
Sensitive 
isolates 
 
Intermediate 
isolates 
 
Resistant 
isolates 
 
Sensitive 
isolates 
 
Intermediate 
isolates 
 
 
Resistant 
isolates 
 
 
Total No. of 
sensitive 
isolates 
Total No. of 
intermediate 
isolates 
 
Total No. of 
resistant 
isolates  
 
Ampicillin 20 (57%) 0 15 (43%) 7 (47%) 0 8 (53%) 27 (54%) 0 23 (46%) 
Gentamicin 17 (49%) 2 (6%) 16 (46%) 8 (53%) 1 (3%) 6 (40%) 25 (50%) 3 22 (44%) 
Tetracycline 10 (29%) 0 25 (71%) 4 (27%) 0 11 (73%) 14 (28%) 0 36 (72%) 
Erythromycin 7 (20%) 5 (14%) 23 (66%) 3 (20%) 0 12 (80%) 10 (20%) 5 35 (70%) 
Ciprofloxacin 13 (37%) 0 22 (63%) 3 (20%) 0 12 (80%) 16 (32%) 0 34 (78%) 
Vancomycin 24 (69%) 0 11 (31%) 11 (73%) 0 4 (27%) 35 (70%) 0 15 (30%) 
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Table 3.5: Antibiotic susceptibility according to biofilm formation 
Antibiotics 
 
Sensitive isolates 
 
Intermediate isolates Resistant isolates 
 
Pearson Chi-
Square 
(fisher's exact test) 
 
 
Biofilm 
former 
 
Biofilm non-
former 
 
Biofilm 
former 
Biofilm non-
former 
Biofilm 
former 
 
Biofilm non-
former 
 
Ampicillin 8 
 
19 
 
0 0 18 
 
5 
 
(.001) Significant 
Gentamicin 17 
 
8 
 
2 
 
1 
 
10 
 
12 
 
(.603) In 
Significant 
Tetracycline 4 10 
 
0 0 27 
 
9 
 
(.003) Significant 
Erythromycin 2 
 
8 
 
1 
 
4 
 
25 
 
10 
 
(.004) Significant 
Ciprofloxacin 6 
 
10 
 
0 0 20 
 
14 
 
(.186) In 
Significant 
Vancomycin 11 
 
24 
 
0 0 12 
 
3 
 
(.002) Significant 
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3.4. PCR detection of esp gene 
Of the 50 enterococci isolates, 25 (50%) were positive for esp gene by PCR as shown in 
(table 3.1). out of which 19 were E. faecalis and 6 for E. faecium. The amplicon size of esp 
gene with the set of primers used was 933 bp. Statistical analysis indicated that there was 
no significant relationship between presence of esp gene and biofilm formation among 
enterococci (P = 0.377) (Table 3.6). 
  
 
 
 
 
 
 
 
 
Figure 3.3.: PCR amplification of esp gene of positive as well as negative E. faecalis (1-
11). M: 100bp marker: PC: Positive control of E. faecalis. NC: Negative control 
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Table 3. 6: Relationship between biofilm-forming and presence of esp gene in 
enterococcal isolates. 
 
Gene Biofilm 
producer (%) 
Non-biofilm 
producer (%) 
Total (%) p-value person 
chi-square 
Esp positive 17 8 25 
.377 
Esp negative 13 12 25 
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Chapter Four: 
___________________________________________________________ 
4. Discussion: 
Enterococci have become an important cause of a variety of infections during the last 
decades, that mainly affect weak and immunocompromised patients and are basically 
hospital-acquired or healthcare associated infections. Often, the ability of enterococci to 
both establish and maintain these infections is directly related to biofilm formation on 
indwelling devices or within the urinary tract itself  (Hatt and Rather 2008). The most 
encountered species are E. faecalis and E. faecium.  
12In our study, of the 50 isolates, E. faecalis was the most encountered with 70% 
(35 isolates) and E. faecium 30% (15 isolates) (Table 3.1). Our finding is in line with 
earlier study in which E. faecalis accounted 74% and E. faecium 26% (Sindhanai, 
Avanthiga et al. 2016). In another study 92% of the isolates were E. faecalis and 8% were 
E. faecium. Higher rates of E. faecalis could be due to its greater inherent virulence 
(Srivastava, Mehta et al. 2013).  
Enterococci are one of the main agents causing urinary tract infection and Catheter-
associated urinary tract infections apart from Gram-negative pathogens  (Tenke, Kovacs et 
al. 2006). In our study greater number of enterococci species were isolated from urine 
specimens (56%) followed by rectal (40%) and wound (4%) (Fig 3.1). Comparable 
observation is seen in the studies conducted by Nautiyalet.al and Jada et.al. (Nautiyal, 
Jauhari et al. , Jada and Jayakumar 2012) They reported that 62.13% and 59% of the 
specimens were urine respectively. 
Examining of antimicrobial susceptibility can lead appropriate antibiotics prescription and 
curbing of emergence of drug resistance (Lakshminarayana, Chavan et al. 2015). In the 
present study E. faecium showed in general higher resistant to the antibiotics used in 
comparison to E. faecalis  without significant association (Fig 3.2) as reported previously. 
(d'Azevedo, Dias et al. 2006, Sharifi, Hasani et al. 2013). In our study highest resistance of 
enterococci (E. faecium) was found to Erythromycin and ciprofloxacin (80%) which was in 
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concordance with other studies (Sreeja, Sreenivasa Babu et al. 2012, Kafil, Mobarez et al. 
2013). The lowest resistance was to vancomycin since 69% (24 isolates) of E. faecalis and 
73% (11 isolates) of E. faecium were sensitive which was in agreement with previous 
study (Hayakawa, Marchaim et al. 2012). 
The isolation of VRE has steadily increased worldwide. A study from the CDC indicates 
that 80% E. faecium isolates were resistant to vancomycin; on the contrary, about 7% 
of E. faecalis isolates were vancomycin‐resistant (Hidron, Edwards et al. 2008). 
In our study we noted high resistance to several antibiotic tested by enterococci species. 
Many of our isolates showed multiple drug resistance which is similar to other studies 
(Rams, Feik et al. 2013, Komiyama, Lepesqueur et al. 2016). The high resistance in our 
study could be explained due to the continuous inappropriate and misuse of antibiotics in 
Palestine. 
Bacterial attachment on surfaces and the development of bacterial communities is an 
important step in infection and biofilm-formers are antimicrobial resistance (Soto 2014). In 
this study the results indicated that 69% of E. faecalis and 40% of E. faecium isolates were 
biofilm producers. Similar studies reported that E. faecalis isolates produce a biofilm more 
often than E. faecium (Mohamed and Huang 2007),(Rosa, Creti et al. 2006). 
In the present study, resistance to some antibiotics including Ampicillin, Tetracycline, 
Erythromycin, and vancomycin, was significantly higher among biofilm than non-biofilm 
producers with p value of (.001), (.003), (.004) and (.002) respectively whereas, resistance 
to gentamycin and ciprofloxacin was insignificant (Table3.5). Several studies showed 
significant relationship between biofilm productions in Enterococci spp. with antibiotic 
resistance (Sandoe, Wysome et al. 2006, White 2007, Akhter, Ahmed et al. 2014). 
 
Biofilm formation and virulence genes have been investigated for enterococci in several 
studies. However, their pathogenicity mechanisms are not well understood (Kafil and 
Mobarez 2015). 
In the present study 50% of enterococcal isolates were found positive for esp gene, there 
was no significant relationship between presence of esp gene and biofilm formation with a 
p value (0.377). Other studies showed that esp promotes  biofilm formation in enterococci 
(Moniri, Ghasemi et al. 2013) , (Soares, Fedi et al. 2014) While other studies have  
suggested that esp gene are not required for enterococci biofilm formation (Dworniczek, 
Wojciech et al. 2005),(Maestre, Aguilar et al. 2012), Several studies pointed out that a 
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variety of virulence factors and  environmental conditions can effect biofilm  formation 
among enterococcus species. 
 
 
4.1. Conclusion: 
Enterococci are recognized as a major cause of nosocomial infections and form biofilms 
that are dependent on multiple genetic factors. Microbial biofilms may pose a public health 
problem. The microorganisms in biofilms are difficult or impossible to treat with 
antimicrobial agents; detachment from the device may result in infection. The results 
suggest that in vitro biofilm formation of enterococci is very complex and the presence of 
esp genes does not appear to be sufficient for the production of biofilm. Further 
investigation is required to understand the biofilm formation. High percentage of resistance 
to the antibiotics used in the study in general and to vancomycin in particular is an 
alarming which require an intervention to control the misuse of antibiotics, this has posed a 
serious problem not only in the treatment of enterococcal infections but also because the 
organism can horizontally transfer this resistant determinant to other Vancomycin-
susceptible species like Staphylococcus aureus. 
 Our study indicated that overall there was a significant relationship between biofilm 
formation of enterococcal isolates and the emergence of antibiotic resistance. The results 
reinforce the role of biofilm formation in resistance to antimicrobial agents in enterococci. 
An understanding of the role of genetic and environmental factors in the development of 
biofilm may lead to improve strategies for biofilm control among enterococci. 
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Appendices 
Bacterial culture media 
Table 1: Bacterial culture media used during this study 
Media Manufacture 
Blood agar Himedia (India) 
Muller Hinton agar Himedia (India) 
TSB media (tryptic soy broth) Himedia (India) 
Bile Esculin agar  Himedia (India) 
Mannitol Salt agar Himedia (India) 
 
 
 
 
Reagent 
Table 2: 
Reagent Manufacture 
Gram stain reagents Sigma (USA) 
DNA molecular weight marker (100) bp 
ladder 
Promega (USA) 
Taq ready Mix Hy.labs 
Primers  TIB MOLBIOL (Germany) 
Antibiotic disks Himedia (India), Oxoid (UK) 
Ethidium bromide Sigma (USA) 
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Equipment 
Table 3: Apparatus and special media that were used in the study 
Thermal cycler Eppendorf 
Research pipettes Eppendorf 
PCR microfuge tube, 0.2ml Eppendorf 
Microwave oven LG 
Elisa reader   
Hoefer shortwave UV light table (trans 
illuminator  
Hoefer (USA) 
Micro-Centrifuge Sanyo (UK) 
Electrophoresis set –up Bio-Rad (USA) 
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 الكشف عن تكوين طبقة البيوفيمم في عينات الانتيروكوكس ومقارنة فحص حساسية المضادات 
 الحيوية 
 دعاء سالم عبد الله جعفري :اعداد 
 : الدكتور حاتم عيدهاشراف
 :الممخص
في تجويف الفم والأمعاء والمسالك التناسمية للإنسان والحيوان  طبيعية، التي تعتبر ت المعويةلمكوراا
كممرضات انتيازية رئيسية. تشكيل بيوفيمم ىو عامل ميم لأنواع المكورات  المكورات المعوية  برزت
 المعوية. البكتيريا داخل البيوفيمم أكثر مقاومة من نظيرتيا الحية الحرة.
) ىي واحدة من أكثر أنواع العدوى المكتسبة في المستشفيات ITUلمسالك البولية (عدوى ا 
مقاومتيا لممضادات الحيوية. إن دور الأغشية  تساىم في ، والتيوالمجتمعات المكتسبة في البشر
لصحة العامة. ومن ىنا أجريت في الو أىمية كبيرة  المضادات الميكروبيةالحيوية البكتيرّية ومقاومة 
لمستشفى لمكورات المعوية جمعت من ا امن  عينات بيوفيمم بواسطة الذه الدراسة لمكشف عن تشكيل ى
بين البكتيريا المكونة نمط مقاومة المضادات الحيوية  مقارنةب قمناو  مجمع رام الله الطبي ستشاري و الا
 .وين البيوفيممفي تك pseجين ال ولتحديد ما ىو الدور الذي يمعبو  غير المكونةلمبيوفيمم و 
، وتم تحديد الأنواع المعوية باستخدام طرق من المكورات المعوية من المرضىعينة  50تم جمع 
بواسطة قرص  عيناتميكروبيولوجية تقميدية. تم تحديد أنماط الحساسية لممضادات الحيوية من ال
 .والمخبرية السريرية المعايير معيدديفيوجن ميثود بالنسبة الى 
لممكورات  عيناتبيوفيمم. تم فحص جميع الالتستخدم لتقييم قدرة تشكيل  retitorciMوحة طريقة ل 
 ).RCP، بواسطة تفاعل البممرة المتسمسل ( pseالمعوية لتحديد الجين المرتبط بالأغشية الحيوية ، 
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 النتائج:
. وفقا فيشيام٪ منيا كانت 50، وفيكاليس٪ منيا عمى أنيا 50، تم التعرف عمى عينة 50من 
مبيوفيمم. كانت مقاومة ل مكوناتالفيشيام  ٪ من 50الفيكاليس و٪ من 69، كان وبشكل عام لنتائجنا،
 = P، ٪00، التتراسيكمين ()100.0 = P٪ 90بعض المضادات الحيوية بما في ذلك الأمبيسمين (
ممحوظ بين منتجين أعمى بشكل  (200.=p( %04( والفانكومايسين , ) ، والإريثروميسين300.0
، لم تكن ٪. في ىذه الدراسة50موجوًدا في عزلات بنسبة  pse. كان الجين منتجينالغير  البيوفيمم من 
 ىناك علاقة ذات دلالة إحصائية بين وجود ىذا الجين وتشكيل بيوفيمم.
 استنتاج :
كانت ،لمضادة لمميكروبات بيوفيمم في مقاومة العوامل االالنتائج التي توصمنا إلييا تعزز دور تشكيل 
. مقارنة مع العينات الغير منتجة لمبيوفيمم ت المنتجة لمبيوفيمم أقل حساسية لممضادات الحيويةيناالع
بيوفيمم يعتمد اللممضادات الحيوية. نتائجنا تشير إلى أن تكوين  ة البكتيريابيوفيمم يقمل من قابميالتشكيل 
 . pseال جين ود عمى وجعمى عوامل مختمفة ولكن ليس فقط 
 بسبب الأخيرة، السنوات في البيوفيمم إنتاج في بدورىا المعروفة لوراثيةا العوامل عدد ازداد قد
 الأبحاث من المزيد إلى حاجة ىناك أن الواضح من ولكن والبروتيومية، الجينومية توافرالمقاربات
 في والبيئية الجينية لدورالعوامل الكامل مالفي يؤدي قد  ،طبقة البيوفيمم إنتاج لتنظيم أفضل بفيم لمسماح
 .المعوية المكورات بين البيوفيمم في التحكم استراتيجيات تحسين إلى تطويرالبيوفيمم
 
 
 
